Last update 04 Nov 2024

Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.

Private Company|
2010|
Guangdong Sheng, China
|
www.evmedical.com.cn

Overview

Tags

Neoplasms
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1

Related

1
Drugs associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
TALC
Target-
Mechanism
Inflammation mediators stimulants
Active Org.
SPC Co., Ltd. (South Korea) [+4]
Originator Org.
Nobelpharma Co., Ltd.Nobelpharma Co., Ltd.
Active Indication
Pneumothorax [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date24 Dec 1997
1
Clinical Trials associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
CTR20222392 / RecruitingPhase 3
一项Ⅲ期、随机、单盲、安慰剂对照平行分组临床试验评估滑石粉治疗恶性胸腔积液的有效性及安全性
[Translation] A phase III, randomized, single-blind, placebo-controlled, parallel-group clinical trial to evaluate the efficacy and safety of talc in the treatment of malignant pleural effusion
100 Clinical Results associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
Login to view more data
100 Deals associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
Login to view more data
100 Translational Medicine associated with Guangzhou Donghe Weixin Medical Technology Development Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
TALC
Malignant Pleural Effusion
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free